Skip to main content
Livermore
Livermore
ZHEN

Grandfield & Dodd, LLC

SEC CIK
0001308016
Latest filing
Aug 7, 2026

NVO holding history

Novo Nordisk A S in every 13F filed by Grandfield & Dodd, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NVO overviewAll 13F holders of NVOFull Q2 2026 holdings

Shares (Q2 2026)
8,507
Value
$407.8K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of NVO by Grandfield & Dodd, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20268,507$407.8K<0.1%00.0%UnchangedHolders
Q1 20268,507$312.6K<0.1%−25−0.3%ReducedHolders
Q4 20258,532$434.1K<0.1%+25+0.3%AddedHolders
Q3 20258,507$472.1K<0.1%00.0%UnchangedHolders
Q2 20258,507$587.2K<0.1%+173+2.1%AddedHolders
Q1 20258,334$578.7K<0.1%−150−1.8%ReducedHolders
Q4 20248,484$729.8K<0.1%−50−0.6%ReducedHolders
Q3 20248,534$1.02M0.1%−20−0.2%ReducedHolders
Q2 20248,554$1.22M0.1%−2,200−20.5%ReducedHolders
Q1 202410,754$1.38M0.1%−1,980−15.5%ReducedHolders
Q4 202312,734$1.32M0.1%+100+0.8%AddedHolders
Q3 202312,634$1.15M0.1%00.0%UnchangedConverted for a 2-for-1 splitHolders
Q2 20236,317$1.02M0.1%−450−6.6%ReducedHolders
Q1 20236,767$1.08M0.1%+100+1.5%AddedHolders
Q4 20226,667$902.3K0.1%00.0%UnchangedHolders
Q3 20226,667$660.0K0.1%−50−0.7%ReducedHolders
Q2 20226,717$750.0K0.1%00.0%UnchangedHolders
Q1 20226,717$750.0K0.1%00.0%UnchangedHolders
Q4 20216,717$750.0K<0.1%00.0%UnchangedHolders
Q3 20216,717$640.0K<0.1%+550+8.9%AddedHolders
Q2 20216,167$520.0K<0.1%00.0%UnchangedHolders
Q1 20216,167$420.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.